Upcoming Allied Market Research
Recombinant Proteins Market

Recombinant Proteins Market: Global Opportunity Analysis and Industry Forecast, 2023-2030 Market

Report Code: A11233
Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.


Recombinant proteins are the novel combination of genes that can be used in the formation of DNA. Recombinant DNA technology helps in the production of wild type and modified human, mammalian proteins in bulk quantities. The proteins are made from cloned DNA sequences that generally encode an enzyme or protein with the known function. They are made through genetic engineering, which is also called gene splicing or recombinant DNA technology. The recombinants can be obtained by putting human, animal, or plant genes into the genetic material of mammalian, bacteria, or yeast cells. These microorganisms can be used as factories or producers to make proteins for medical, academic, and research uses. The recombinant DNA is inserted into expression vectors that contain the promoter, ribosome binding site, and terminator.


COVID-19 scenario analysis:

The foremost part done by the government was to shake hands with the Pharmaceutical and Biotechnology industries in order to combat with the outbreak of the pandemic. The government invested a higher amount on the development of various vaccines which could ultimately help in the managements of the people infected with the COVID-19 disease. There are 115 vaccine candidates and 155 molecules which are proposed to be in the R&D pipeline. The previously available drugs were also tested to be used to treat the diseases, one of such medication is Hydroxychloroquine, which is observing a higher demand that the earlier. This has presented huge opportunity for the manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Due to the rising demand for the vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is forecasted to witness a significant growth in the future.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The market is driven by the factors such as, rise in the prevalence of the chronic diseases, growth in the inclination towards biosimilars and biologics and the improvement in the recombinant products would help the market boost in the forecast period. Furthermore, the higher amount is getting invested on the R&D of the products which are segmented under the recombinant proteins, which is anticipated to help the market grow in the coming years. However, the lack of skilled medical professionals in the field of the recombinant proteins may hinder the industrial growth in the commenced period.

New product advancements to flourish the market

In October 2018, Leadiant Biosciences, Inc. announced that the Food and Drug Administration (FDA) had granted approval to Revcovi (elapegademase-lvlr) injection in the U.S. The product Revcovi is a new enzyme replacement therapy (ERT) which can be used for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients.

In March 2020, AMS Biotechnology had announced the availability of recombinant proteins and antibodies for the detection of Coronavirus (COVID-19) and related RNA viruses. AMSBIO provides leading-edge life science technology, products and services for R&D in the medical, nutrition, cosmetics and energy industries.

Surge in mergers and acquisitions to boost the market

In August 2017, Sanofi has completed the acquisition vaccine development firm Protein Sciences which is in United States. The acquisition helps n expanding the company’s portfolio and helps in the cumulative effect of the distribution channels available for both of the companies, hence gaining maximum revenue in the coming years.

In August 2019, Nucleus Biologics, which is a leader in precision cell culture, is pleased to announce the acquisition of Primorigen Biosciences, Inc. The addition of Primorigen's Vitronectin XF and platform recombinant protein production technology will help Nucleus' strategy of offering traceable, reproducible and xeno-free (XF) cell culture ecosystems for the cell and gene therapy space.

Key benefits of the report:

  • This study presents the analytical depiction of the global Recombinant Proteins industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Recombinant Proteins market share.
  • The current market is quantitatively analyzed to highlight the global Recombinant proteins market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the Recombinant proteins market.
  • The report provides a detailed global Recombinant proteins market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Recombinant Proteins Market research report:

  • Who are the leading market players active in the Recombinant Proteins market?
  • What are the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in tasking further strategic steps?

Recombinant Proteins Market: Global Opportunity Analysis and Industry Forecast, 2020–2027 Report Highlights

Aspects Details
By Type
  • Antibodies
  • Hormones
  • Growth Factors
  • Cytokines
  • Others
By Application
  • Therapeutic Use
  • Research Application
  • Biotechnology Industry
By End User
  • Biotechnology Companies
  • Research Institutes
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Rest of LAMEA)
Key Market Players Sanofi SA, Amgen Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Eli Lilly and Company, Merck KGaA, Abcam PLC, Novo Nordisk AS, ProSpec-Tany TechnoGene Ltd, Enzo Biochem, Inc (Enzo Life Sciences Inc.)

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Purchase Options

Call or Email Us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Recombinant Proteins Market

Start reading.
This Report and over 71,295+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Related Reports

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of the scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time for readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of the scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save the time of readers